All Curated Mutation Sites in EBOV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in EBOV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
GP
  
L
  
NP
  
VP24
  
VP35
  
VP40
  

Keyword: NP
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 38278475 R635K
NP
NP
Hemorrhagic fever, ebola
G
R
View
2 27847361 R111C
NP
NP
Hemorrhagic fever, ebola
G
S
L
View
3 34484156 R111C
NP
NP
Hemorrhagic fever, ebola
G
View
4 36946725 R111C
NP
NP
Hemorrhagic fever, ebola
R
S
View
5 37333330 E619K
NP
NP
Cell line
R
T
View
6 31717793 C2357A
NP
NP
Cell line
I
T
View
7 31717793 H630N
NP
NP
Cell line
I
T
View
8 31717793 S72G
NP
NP
Cell line
I
T
View
9 40288648 E619K
NP
NP
Cell line
D
R
S
T
View
10 39726359 T603D
NP
NP
Cell line
View
11 39726359 T603I
NP
NP
Cell line
View
12 33141416 L692A
NP
NP
Cell line
G
View
13 33141416 P697A
NP
NP
Cell line
G
View
14 33141416 P698A
NP
NP
Cell line
G
View
15 33141416 W699A
NP
NP
Cell line
G
View
16 30333174 R111C
NP
NP
Cell line
G
R
View
17 31952352 K109E
NP
NP
Cell line
G
R
View
18 31952352 K110E
NP
NP
Cell line
G
R
View
19 31952352 R111C
NP
NP
Cell line
G
R
View
20 31952352 R111E
NP
NP
Cell line
G
R
View
21 30524754 C170A
NP
NP
Cell line
R
View
22 30524754 C1805T
NP
NP
Cell line
R
View
23 30524754 C1958T
NP
NP
Cell line
R
View
24 30524754 P446S
NP
NP
Cell line
R
View
25 30524754 P497S
NP
NP
Cell line
R
View
26 30524754 S580
NP
NP
Cell line
R
View
27 30524754 T172C
NP
NP
Cell line
R
View
28 30524754 T2209C
NP
NP
Cell line
R
View
Contents
Description

The table shows all curated mutation sites of EBOV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.